Your browser doesn't support javascript.
loading
Systematic review of MRI alterations in the brain following proton and photon radiation therapy: Towards a uniform European Particle Therapy Network (EPTN) definition.
Lauwens, Lieselotte; Ribeiro, Marvin F; Zegers, Catharina M L; Høyer, Morton; Alapetite, Claire; Blomstrand, Malin; Calugaru, Valentin; Di Perri, Dario; Iannalfi, Alberto; Lütgendorf-Caucig, Carola; Paulsen, Frank; Postma, Alida A; Romero, Alejandra Méndèz; Timmermann, Beate; Troost, Esther G C; van der Weide, Hiska L; Whitfield, Gillian A; Harrabi, Semi; Lambrecht, Maarten; Eekers, Daniëlle B P.
Afiliação
  • Lauwens L; KU Leuven, University of Leuven, Department of Oncology, Laboratory of Experimental Radiotherapy, Leuven, Belgium; University Hospitals Leuven, Department of Radiation Oncology, Leuven, Belgium. Electronic address: Lieselotte.lauwens@kuleuven.be.
  • Ribeiro MF; Department of Radiation Oncology (Maastro), GROW Research Institute for Oncology and Reproduction, Maastricht. University Medical Centre+, Maastricht, the Netherlands; Mental Health and Neuroscience research institute (Mhens) Faculty of Health Medicine and Life Sciences, Maastricht University, Maast
  • Zegers CML; Department of Radiation Oncology (Maastro), GROW Research Institute for Oncology and Reproduction, Maastricht. University Medical Centre+, Maastricht, the Netherlands.
  • Høyer M; Danish Centre for Particle Therapy, Aarhus University Hospital, Denmark.
  • Alapetite C; Institut Curie, Radiation Oncology Department, Paris & Proton Center, Orsay, France.
  • Blomstrand M; Department of Oncology, Sahlgrenska University Hospital Gothenburg and the Skandion Clinic, Sweden.
  • Calugaru V; Institut Curie, Radiation Oncology Department, Paris & Proton Center, Orsay, France.
  • Di Perri D; Department of Radiation Oncology, Cliniques universitaires Saint-Luc, Brussels, Belgium; Particle Therapy Interuniversitary Center Leuven (PartICLe), Belgium.
  • Iannalfi A; Clinical Department, Radiotherapy Unit, National Center for Oncological Hadrontherapy (C.N.A.O.), Italy.
  • Lütgendorf-Caucig C; MedAustron Ion Therapy Center, 2700 Wiener Neustadt, Austria; Radioonkologie, Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Ger
  • Paulsen F; Clinic for Radiation Oncology, Eberhard-Karls-University, Tuebingen, Germany.
  • Postma AA; Mental Health and Neuroscience research institute (Mhens) Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center, Maastricht, the Netherlands.
  • Romero AM; Department of Radiotherapy, Erasmus MC Cancer Institute, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
  • Timmermann B; Department of Particle Therapy, West German Proton Therapy Centre Essen (WPE), University Hospital Essen, Germany.
  • Troost EGC; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany; National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany: German Cancer
  • van der Weide HL; University of Groningen, University Medical Center Groningen, Department of Radiation Oncology, Hanzeplein 1, 9713GZ Groningen, the Netherlands.
  • Whitfield GA; The Christie Proton Beam Therapy Centre, The Christie NHS Foundation Trust, Manchester, United Kingdom; University of Manchester, Royal Manchester Children's Hospital, The Children's Brain Tumour Research Network, Manchester, United Kingdom.
  • Harrabi S; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
  • Lambrecht M; KU Leuven, University of Leuven, Department of Oncology, Laboratory of Experimental Radiotherapy, Leuven, Belgium; University Hospitals Leuven, Department of Radiation Oncology, Leuven, Belgium; Particle Therapy Interuniversitary Center Leuven (PartICLe), Belgium.
  • Eekers DBP; Department of Radiation Oncology (Maastro), GROW Research Institute for Oncology and Reproduction, Maastricht. University Medical Centre+, Maastricht, the Netherlands.
Radiother Oncol ; 208: 110936, 2025 Jul.
Article em En | MEDLINE | ID: mdl-40360047
Magnetic resonance imaging (MRI) often demonstrates alterations following cranial radiotherapy (RT), which may result in clinical symptoms and diagnostic uncertainty, and thus potentially impact treatment decisions. The potential differences in MRI alterations after proton and photon RT, has raised concerns regarding the relative biological effectiveness of proton therapy. To provide an overview of MRI alterations in the brain post-RT and to explore differences between photon and proton RT, a systematic review adhering to the PRISMA guidelines was conducted, focusing on the assessment methods and definitions across studies. A systematic search of three electronic databases was performed using the concepts 'normo-fractionated radiotherapy ', 'MRI alterations' and 'brain, skull base or head and neck tumours in adult and paediatric populations'. Data extraction and quality assessment was performed on articles meeting the predefined criteria by two independent reviewers. Out of 5887 screened studies, 94 met the inclusion criteria. These studies were categorized based on confinement of the MRI alterations to temporal lobe, brainstem, or across the entire brain. Additional subclassification was performed based on MRI sequences evaluated or by the nature of the alterations, with pseudoprogression generally reserved for glioma patients. While many papers exist on MRI alterations in the brain after RT, this review highlights significant inconsistencies in the terminology and definitions, limiting the comparability of findings across studies. Our results highlight the need for and facilitate the development of a standardized framework for describing MRI alterations after RT.
Assuntos

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Prevencao_e_fatores_de_risco / Agentes_cancerigenos / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Encéfalo / Neoplasias Encefálicas / Imageamento por Ressonância Magnética / Fótons / Terapia com Prótons Tipo de estudo: Guideline / Literature_review / Systematic_reviews Limite: Humans Idioma: En Revista: Radiother oncol Ano de publicação: 2025 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Prevencao_e_fatores_de_risco / Agentes_cancerigenos / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Encéfalo / Neoplasias Encefálicas / Imageamento por Ressonância Magnética / Fótons / Terapia com Prótons Tipo de estudo: Guideline / Literature_review / Systematic_reviews Limite: Humans Idioma: En Revista: Radiother oncol Ano de publicação: 2025 Tipo de documento: Article